Topics

Senior Vice President, Market Development, at ConnectiveRx.

Articles

A four-pillar strategy to help ensure both, as copay programs face mounting payer pressure and misuse in 2026.

Your Copay Program Is Protecting Access. Is It Also Protecting Gross-to-Net?

Policy shifts bring meaningful improvements for some—but looming coverage losses and rising premiums threaten to erase those gains.

What Does Healthcare Look Like for Patients in 2026?

By unifying data, workflows, and decision-making across partners, AI orchestration is enabling healthcare supply chains to move from reactive firefighting to proactive resilience—supporting faster responses, smarter tradeoffs, and more reliable patient care delivery.

How AI Orchestration Is Reinventing Healthcare Supply Chain Resilience

. He can be reached at nsaraceno@mjhlifesciences.com.

Podcasts

In today’s Pharma Pulse, a new national survey exposes the depth of America’s prescription access crisis, while AstraZeneca and Eli Lilly commit billions of dollars to next-generation weight-loss therapies and domestic manufacturing.

Pharma Pulse: The Access Gap

This guide breaks down how AFPs function and why they are fundamentally changing the path between patients and their therapies.

FAQ: Decoding Alternative Funding Programs

In today’s Pharma Pulse, the AAP defies federal vaccine cuts, Morris & Dickson scales its specialty footprint, and Insilico Medicine targets cardiometabolic health with a new partnership.

Pharma Pulse: AI’s $120M Cardiometabolic Play

In today’s Pharma Pulse, extreme weather tests the resilience of community pharmacies, while CMS proposes a near-flat 0.09% update for Medicare Advantage and Part D payments in 2027.

Pharma Pulse: Climate Risks to the Supply Chain 

In today’s Pharma Pulse, global pharmaceutical production hits a surge as manufacturers brace for US tariff shifts, while a new study reveals how smart speakers are slashing A1C levels for older adults.

Pharma Pulse: Manufacturing Front-Loading and the Smart Speaker Intervention

How direct-to-patient programming can transform the prescription journey for patients and manufacturers alike.

Why Direct-to-Patient Is the Pharma Industry’s Next Power Move

Videos

In the second part of his Pharma Commerce video interview, Hari Kiran Chereddi, CEO of HRV Pharma, describes how AI-driven orchestration, real-time data integration, and federated learning are reshaping pharmaceutical supply chains for faster, safer, and more agile operations.

Patient Support